Literature DB >> 1600714

The diabetes annual review as an educational tool: assessment and learning integrated with care, screening, and audit. The North Tyneside Diabetes Team.

.   

Abstract

An integrated diabetes Annual Review is described, suitable for the long-term care of large numbers of diabetic patients. Equal weight is given to dietary and educational assessment as to medical care and screening. Based on well-developed team-work the patient moves through a structured review which culminates in goal setting and planned care for the subsequent year. A structured audit of the review was carried out on a cohort of 123 patients of whom 67 had had two annual reviews. Ten patients failed to attend. Knowledge scores improved by 44% between first and second reviews. In 34% of patients in the first year and in 46% in year two, HbA1c levels were outside a target range set for each treatment group, but only 18% had results outside target in both years. A postal questionnaire was returned by 74/108 (69%) patients. This indicated a high level of patient participation and satisfaction with the review process. The diabetes team set standards, conducted the review, and subsequently changed in-house working practices and documentation, and developed in-service training.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600714

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  2 in total

Review 1.  Pharmacoeconomics of diabetes surveillance and detection programmes.

Authors:  P D Home
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

2.  The Year of Care approach: developing a model and delivery programme for care and support planning in long term conditions within general practice.

Authors:  Sue Roberts; Simon Eaton; Tracy Finch; Nick Lewis-Barned; Monique Lhussier; Lindsay Oliver; Tim Rapley; Dawn Temple-Scott
Journal:  BMC Fam Pract       Date:  2019-11-08       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.